David A. Ricks - Feb 10, 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
President, Chair, and CEO, Director
Signature
/s/ Jonathan Groff for David A. Ricks, pursuant to authorization on file
Stock symbol
LLY
Transactions as of
Feb 10, 2023
Transactions value $
$19,398,505
Form type
4
Date filed
2/14/2023, 04:01 PM
Previous filing
Feb 3, 2023
Next filing
Apr 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Gift $0 -4.2K -1.07% $0.00 388K Feb 8, 2023 Direct F1
transaction LLY Common Stock Award $19.4M +56.2K +14.5% $345.12 444K Feb 10, 2023 Direct
holding LLY Common Stock 67.7K Feb 10, 2023 By David A. Ricks SLAT F2
holding LLY Common Stock 70K Feb 10, 2023 By David A. Ricks 2022 GRAT
holding LLY Common Stock 7.17K Feb 10, 2023 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Award $0 +29.6K $0.00 29.6K Feb 10, 2023 Common Stock 29.6K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 8, 2023, the Reporting Person transferred 4,200 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's wife is the trustee and the Reporting Person's wife and children are beneficiaries. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.
F2 The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.